Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- ZOLARMABIndependent statistical analysis of Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03087851).
- Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement: Complete Statistical AnalysisIndependent statistical analysis of Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Zoliflodacin in Uncomplicated Gonorrhoea: Complete Statistical AnalysisIndependent statistical analysis of Zoliflodacin in Uncomplicated Gonorrhoea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03959527).
- ZoMARSIndependent statistical analysis of Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Zonisamide vs. Placebo in the Treatment of Alcohol Dependence: Complete Statistical AnalysisIndependent statistical analysis of Zonisamide vs. Placebo in the Treatment of Alcohol Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00595556).
- ZOROIndependent statistical analysis of A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors: Complete Statistical AnalysisIndependent statistical analysis of ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02444936).
- ZPIndependent statistical analysis of In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03782103).
- ZUMA-1Independent statistical analysis of Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ZUMA-12Independent statistical analysis of Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Participants With High-Risk Large B-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval,…
- ZUMA-2Independent statistical analysis of Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 1 and Cohort 2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ZvLIndependent statistical analysis of Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ZW25 in Women With Endometrial Cancers: Complete Statistical AnalysisIndependent statistical analysis of ZW25 in Women With Endometrial Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04513665).
- β-SPECIFIC 3Independent statistical analysis of An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active…